Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas

Journal of Neuro-Oncology

Volumn 50, Issue 3, 2000, Pages 207-213

  Leuraud, P ^a   Marie, Y ^a   Robin, E ^a   Huguet, S ^a   He, J ^a   Mokhtari, K ^a   Cornu, P ^a   Hoang Xuan, K ^a   Sanson, M ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Laboratoire d'Histologie Embryologie Cyto tique   (France)

Author keywords

CDKN2C; Chromosome 1; Meningioma; p18

Indexed keywords

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 1; CHROMOSOME 1P; CHROMOSOME 22; CHROMOSOME DELETION; CHROMOSOME INACTIVATION; CHROMOSOME MARKER; CONTROLLED STUDY; DNA POLYMORPHISM; GENE MUTATION; GENE SEQUENCE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MENINGIOMA; P18 GENE; SEQUENCE ANALYSIS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ALLELES; BLOTTING, SOUTHERN; CARRIER PROTEINS; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 22; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASES; DNA PRIMERS; ENZYME INHIBITORS; GENE DELETION; GENES, TUMOR SUPPRESSOR; HOMOZYGOTE; HUMANS; LOSS OF HETEROZYGOSITY; MENINGEAL NEOPLASMS; MENINGIOMA; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

EID: 0034474968     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006400723490     Document Type: Article

References (31)

1. Chromosomal constitution of meningiomas
2. Molecular genetic analysis of chromosome 22 in 81 cases of meningiomas
3. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2
4. Predominant occurence of somatic mutations of the NF2 gene in meningiomas and schwannomas
5. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: A genetic model of meningioma progression
6. Identification of a consistent region of allelic loss on 1p32 in meningiomas: Correlation with increased morbidity
7. Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas
8. Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32
9. Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors
10. Homozygous deletions of the CDKN2C/p18INK4C gene on the short arm of the chromosome 1 in anaplastic oligodendrogliomas
11. Characterisation of 16 polymorphic markers in the NF2 gene
12. Allelic loss on chromosome 22 and prediction of recurrence in meningioma
13. Intragenic mutations of the p16 INK4, p15 INK4B and p18 genes in primary non-small-cell lung cancers
14. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas
15. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression
16. Growth suppression by p18, a p16 INK4/MTS1 and p14 INK4B/MT52-related CDK6 inhibitor, correlates with wild-type pRb function
17. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16 INK4A, p18 INK4C, p19 INK4D, p21 WAF1/CIP1 and p27 KIP1 in inducing cell arrest, apoptosis and inhibition of tumorigenicity
18. Analysis of the p16 INK4A, p15 INK4B and p18 INK4C genes in multiple myeloma
19. Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia
20. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias
21. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors 15 INK4b and p18 INK4c in tumor-derived cell lines and primary tumors
22. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer
23. P18 mutation and progression of oligodendroglioma to anaplasia
24. Mutations in the p16 INK4/MTS1/CDKN2, p15 INK4B/MTS2, and p18 genes in primary and metastatic lung cancer
25. Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma
26. Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18 (INK4C) and p27 (Kip1) genes in neuroblastomas
27. Molecular analysis of the INK4 family of genes in prostate carcinomas
28. Alterations of the p15, p16, and p18 genes in osteosarcoma
29. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas
30. Molecular analysis of alterations of the p18INK4c gene in human meningiomas